Nils Bömer

2.4k total citations · 1 hit paper
50 papers, 1.1k citations indexed

About

Nils Bömer is a scholar working on Molecular Biology, Rheumatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nils Bömer has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Rheumatology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nils Bömer's work include Osteoarthritis Treatment and Mechanisms (15 papers), Selenium in Biological Systems (8 papers) and Cancer-related molecular mechanisms research (7 papers). Nils Bömer is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (15 papers), Selenium in Biological Systems (8 papers) and Cancer-related molecular mechanisms research (7 papers). Nils Bömer collaborates with scholars based in Netherlands, United Kingdom and United States. Nils Bömer's co-authors include Peter van der Meer, Ingrid Meulenbelt, Wouter den Hollander, Y.F. Ramos, Rob G. H. H. Nelissen, P. Eline Slagboom, Nico Lakenberg, Ruud van der Breggen, Steffan D. Bos and Niels Grote Beverborg and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Nils Bömer

47 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging

2024 82 citations Annet N. Linders, Nils Bömer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nils Bömer Netherlands	19	398	376	234	208	177	50	1.1k
Chang Hyun Byon United States	11	160 0.4×	549 1.5×	136 0.6×	185 0.9×	156 0.9×	12	1.4k
De-min Yu China	18	75 0.2×	407 1.1×	50 0.2×	160 0.8×	180 1.0×	45	1.2k
Hongfeng Ruan China	18	147 0.4×	466 1.2×	101 0.4×	102 0.5×	13 0.1×	61	911
Xingzhi Jing China	19	391 1.0×	776 2.1×	77 0.3×	365 1.8×	19 0.1×	41	1.5k
Eve Rigal France	12	77 0.2×	470 1.3×	52 0.2×	265 1.3×	83 0.5×	30	1.0k
Robert G. Spanheimer United States	22	94 0.2×	545 1.4×	99 0.4×	72 0.3×	161 0.9×	44	1.4k
Yan Han China	18	104 0.3×	374 1.0×	100 0.4×	200 1.0×	19 0.1×	38	740
Doron Shinar Israel	12	233 0.6×	1.1k 3.0×	51 0.2×	142 0.7×	25 0.1×	16	1.7k
G.C. Gurtner United States	9	115 0.3×	448 1.2×	277 1.2×	91 0.4×	67 0.4×	27	1.8k

Countries citing papers authored by Nils Bömer

Since Specialization

Citations

This map shows the geographic impact of Nils Bömer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Bömer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Bömer more than expected).

Fields of papers citing papers by Nils Bömer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils Bömer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Bömer. The network helps show where Nils Bömer may publish in the future.

Co-authorship network of co-authors of Nils Bömer

This figure shows the co-authorship network connecting the top 25 collaborators of Nils Bömer. A scholar is included among the top collaborators of Nils Bömer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils Bömer. Nils Bömer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silljé, Herman H.W., et al.. (2025). Glutathione deficiency and heart failure: a systematic review of human and animal evidence. University of Groningen research database (University of Groningen / Centre for Information Technology). 15. 100131–100131.

Silljé, Herman H.W., et al.. (2025). RNA Therapeutics in Heart Failure. Journal of Cardiovascular Translational Research. 18(6). 1540–1554.

Brouwer, Remco de, et al.. (2025). Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohort. Netherlands Heart Journal. 33(4). 112–119. 1 indexed citations

Buist‐Homan, Manon, Nils Bömer, Vincent E. de Meijer, et al.. (2024). Branched-chain amino acids and their metabolites decrease human and rat hepatic stellate cell activation. Molecular Biology Reports. 51(1). 1116–1116. 1 indexed citations

Bömer, Nils, Ramón Bartolo, Hjalmar P. Permentier, et al.. (2023).   A high-throughput screening strategy identifies adenosine 5'-monophosphate as a novel enhancing molecule of the cardio-protective enzyme 5-oxoprolinase (OPLAH). European Heart Journal. 44(Supplement_2). 1 indexed citations

Bömer, Nils, Jasper Tromp, Kenneth Dickstein, et al.. (2023). Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D. International Journal of Cardiology. 396. 131384–131384. 7 indexed citations

Sánchez-Aguilera, Pablo, Camila López‐Crisosto, Ignacio Norambuena‐Soto, et al.. (2023). IGF-1 boosts mitochondrial function by a Ca2+ uptake-dependent mechanism in cultured human and rat cardiomyocytes. Frontiers in Physiology. 14. 1106662–1106662. 8 indexed citations

Markousis‐Mavrogenis, George, et al.. (2023). Immunomodulation and immunopharmacology in heart failure. Nature Reviews Cardiology. 21(2). 119–149. 21 indexed citations

Dokter, Martin M., Kenneth Dickstein, Chim C. Lang, et al.. (2023). Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease. Cardiovascular Diabetology. 22(1). 8–8. 10 indexed citations

10.

Pávez, Mario, Pablo Sánchez-Aguilera, Nils Bömer, et al.. (2021). ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ. International Journal of Molecular Sciences. 22(9). 4427–4427. 10 indexed citations

11.

Bömer, Nils, Mario Pávez, Annet N. Linders, et al.. (2021). Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human Cardiomyocytes. International Journal of Molecular Sciences. 22(21). 11906–11906. 18 indexed citations

12.

Ricke‐Hoch, Melanie, Martijn F. Hoes, Tobias J. Pfeffer, et al.. (2019). In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles. Cardiovascular Research. 116(11). 1875–1886. 27 indexed citations

13.

Bömer, Nils, Niels Grote Beverborg, Martijn F. Hoes, et al.. (2019). Selenium and Outcome in Heart Failure. European Journal of Heart Failure. 22(8). 1415–1423. 108 indexed citations

14.

Hoes, Martijn F., Jasper Tromp, Wouter Ouwerkerk, et al.. (2019). The Role of Cathepsin D in the Pathophysiology of Heart Failure and its Potentially Beneficial Properties: A Translational Approach. European Journal of Heart Failure. 22(11). 2102–2111. 23 indexed citations

15.

Ovchinnikova, Ekaterina S., Martijn F. Hoes, Kirill Ustyantsev, et al.. (2018). Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes. Stem Cell Reports. 10(3). 794–807. 42 indexed citations

16.

Bosch, M.H. van den, Y.F. Ramos, W. den Hollander, et al.. (2017). Increased expression of CCN4/WISP1 in osteoarthritic articular cartilage is epigenetically regulated and disrupts cartilage homeostasis. Osteoarthritis and Cartilage. 25. S38–S38. 1 indexed citations

17.

Bömer, Nils, F.M. Cornelis, Y.F. Ramos, et al.. (2016). Aberrant Calreticulin Expression in Articular Cartilage of Dio2 Deficient Mice. PLoS ONE. 11(5). e0154999–e0154999. 2 indexed citations

18.

Bömer, Nils, Wouter den Hollander, H. Eka D. Suchiman, et al.. (2016). Neo-cartilage engineered from primary chondrocytes is epigenetically similar to autologous cartilage, in contrast to using mesenchymal stem cells. Osteoarthritis and Cartilage. 24(8). 1423–1430. 23 indexed citations

19.

Boer, Cindy G., Roberto Narcisi, Y.F. Ramos, et al.. (2015). Genetic variants in the SUPT3H-RUNX2 locus confer susceptibility for bone and cartilage related disorders via long-range regulation of RUNX2. Osteoarthritis and Cartilage. 23. A71–A71. 3 indexed citations

20.

Hollander, Wouter den, Y.F. Ramos, Steffan D. Bos, et al.. (2014). Knee and hip articular cartilage have distinct epigenomic landscapes: implications for future cartilage regeneration approaches. Annals of the Rheumatic Diseases. 73(12). 2208–2212. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact